Literature DB >> 12421264

Septic arthritis in patients followed-up in neonatal intensive care unit.

Sevki Kabak1, Mehmet Halici, Mustafa Akcakus, Neside Cetin, Nazmi Narin.   

Abstract

BACKGROUND: Septic arthritis is an uncommon, but serious disorder in neonates. Most patients survive with permanent handicaps. Due to the rarity of this condition in neonates and paucity of signs and symptoms, the diagnosis of septic arthritis in newborns is more difficult than in older children.
METHODS: Septic arthritis or suppurative arthritis is an infection of the joint by a variety of microorganisms, including bacteria, viruses, mycobacteria and fungi. Purulent synovial fluid, positive culture and positive Gram stain were accepted as a gold standard for exact diagnosis. Fourteen neonates who were followed-up in a neonatal intensive care unit, with septic arthritis, were included in a study based on a review of medical reports and a long-term clinical and radiological follow-up. Clinical symptoms, bacteriology, risk factors and outcomes are discussed.
RESULTS: Staphylococcus aureus was the predominant causative organism. Risk factors for septic arthritis were prematurity (4/14), umbilical catheterization or venous catheterization (3/14), sepsis (3/14), perinatal asphyxia (2/14) and difficult birth (1/14). All cases of septic arthritis in neonates were improved without squealae except in two patients. One patient died and one patient had severe squealae. In these two patients, the duration of disease from clinical onset to initiation of therapy was long.
CONCLUSIONS: The most important prognostic factor in predicting a favorable outcome in neonatal septic arthritis is early diagnosis and therapy. When appropriate treatment is delayed, catastrophic sequelae are inevitable. Early diagnosis of the condition and rapid removal of pus are mandatory for the survival of the joint. Long-term follow-up may reveal effects of epiphyseal damage, early degenerative changes and limitation of the range of motion.

Entities:  

Mesh:

Year:  2002        PMID: 12421264     DOI: 10.1046/j.1442-200x.2002.01649.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  8 in total

1.  Current clinical and bacteriological profile of septic arthritis in young infants: a prospective study from a tertiary referral centre.

Authors:  Gireesh Sankaran; Balaji Zacharia; Antony Roy; Sulaikha Puthan Purayil
Journal:  Eur J Orthop Surg Traumatol       Date:  2018-02-09

2.  Current trends of microorganisms and their sensitivity pattern in paediatric septic arthritis: A prospective study from tertiary care level hospital.

Authors:  Girish Motwani; Rujuta Mehta; Alaric Aroojis; Sandeep Vaidya
Journal:  J Clin Orthop Trauma       Date:  2016-09-28

3.  Neonatal septic arthritis in a tertiary care hospital: a descriptive study.

Authors:  T Sreenivas; A R Nataraj; Anand Kumar; Jagdish Menon
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-05-06

4.  Neonatal septic arthritis: Indian perspective.

Authors:  Akash Rai; Debrup Chakladar; Souravi Bhowmik; Tanushree Mondal; Arnab Nandy; Biplab Maji; Avijit Hazra; Rakesh Mondal
Journal:  Eur J Rheumatol       Date:  2020-02

5.  Treatment of Septic Arthritis of the Hip Joint Using Repeated Aspirations: When Should We Operate?

Authors:  Gilad Rotem; Noa Zur-Aviran; Nir Sherr-Lurie; Daniel Weltsch; Amos Schindler; Shay Tenenbaum; Uri Givon
Journal:  Indian J Orthop       Date:  2022-04-04       Impact factor: 1.033

6.  A Neonatal Septic Arthritis Case Caused by Klebsiella pneumoniae: A Case Report.

Authors:  Tamer Ozsari; Gülhan Bora; Özmert M A Ozdemir; Ilknur Kiliç
Journal:  J Clin Diagn Res       Date:  2016-02-01

7.  Prognostic factors of septic arthritis of hip in infants and neonates: minimum 5-year follow-up.

Authors:  Soon Chul Lee; Jong Sup Shim; Sung Wook Seo; Sung San Lee
Journal:  Clin Orthop Surg       Date:  2015-02-10

Review 8.  Delayed treatment of septic arthritis in the neonate: A review of 52 cases.

Authors:  YiQiang Li; QingHe Zhou; YuanZhong Liu; WeiDong Chen; JingChun Li; Zhe Yuan; BiCheng Yong; HongWen Xu
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.